Neuroimaging in amyotrophic lateral sclerosis

被引:36
|
作者
Comi, G [1 ]
Rovaris, M [1 ]
Leocani, L [1 ]
机构
[1] Osped San Raffaele, Inst Sci, Dept Neurophysiol, I-20132 Milan, Italy
关键词
amyotrophic lateral sclerosis; magnetic resonance spectroscopy; magnetization transfer imaging; diffusion weighted imaging;
D O I
10.1046/j.1468-1331.1999.660629.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Amyotrophic lateral sclerosis (ALS) is a chronic degenerative disorder of unknown etiology affecting the motor system. Conventional and non-conventional neuroimaging techniques can provide essential help both to increase the confidence in ALS diagnosis and to assess the disease evolution. Signal abnormalities at the level of the motor cortex and the corticospinal tract on conventional T2-weighted magnetic resonance (MR) images are a potentially useful marker of ALS pathology. However, the prognostic value of these conventional MR abnormalities is still hampered by their low pathological specificity. Non-conventional MR techniques with a higher pathological specificity, such as MR spectroscopy, magnetization transfer imaging and diffusion-weighted imaging, seem to have some potential not only for ALS diagnosis, but also for monitoring disease evolution either naturally or when modified by experimental treatments. Eur J Neurol 6:629-637 (C) 1999 Lippincott Williams & Wilkins.
引用
收藏
页码:629 / 637
页数:9
相关论文
共 50 条
  • [41] The skin in amyotrophic lateral sclerosis
    Ono, S
    AMYOTROPHIC LATERAL SCLEROSIS AND OTHER MOTOR NEURON DISORDERS, 2000, 1 (03): : 191 - 199
  • [42] The management of amyotrophic lateral sclerosis
    Phukan, Julie
    Hardiman, Orla
    JOURNAL OF NEUROLOGY, 2009, 256 (02) : 176 - 186
  • [43] Management of Amyotrophic Lateral Sclerosis
    Philippe Corcia
    Vincent Meininger
    Drugs, 2008, 68 : 1037 - 1048
  • [44] Amyotrophic lateral sclerosis: an update
    Prida Javier, Marin
    REVISTA MEXICANA DE NEUROCIENCIA, 2009, 10 (04): : 281 - 286
  • [45] Amyotrophic lateral sclerosis and prolactinoma
    Kararizou, Evangelia
    Stamboulis, Elevtherios
    Markou, Ioannis
    Alevizaki, Maria
    Gkiatas, Konstantinos
    FUNCTIONAL NEUROLOGY, 2007, 22 (01) : 39 - 41
  • [46] The pathogenesis of amyotrophic lateral sclerosis
    Robberecht, W
    Van den Bosch, L
    NEUROSCIENCE RESEARCH COMMUNICATIONS, 1998, 23 (02) : 67 - 75
  • [47] Pathogenesis of amyotrophic lateral sclerosis
    Morgan, Sarah
    Orrell, Richard W.
    BRITISH MEDICAL BULLETIN, 2016, 119 (01) : 87 - 97
  • [48] Treatments for amyotrophic lateral sclerosis
    Camu, William
    Buxeraud, Jacques
    Fougere, Edouard
    ACTUALITES PHARMACEUTIQUES, 2020, 59 (593): : 29 - 33
  • [49] Biomarkers in amyotrophic lateral sclerosis
    Turner, Martin R.
    Kiernan, Matthew C.
    Leigh, P. Nigel
    Talbot, Kevin
    LANCET NEUROLOGY, 2009, 8 (01) : 94 - 109
  • [50] Familial amyotrophic lateral sclerosis
    Siddique, T
    Hentati, A
    CLINICAL NEUROSCIENCE, 1996, 3 (06) : 338 - 347